<DOC>
	<DOCNO>NCT01305525</DOCNO>
	<brief_summary>This prospective non-interventional 24 month post implant registry . Any patient receives St. Jude Medical FDA approve implantable neuromodulation system eligible enrollment . A minimum 600 patient enrol minimum 30 site . Patients enrol post-implant follow 24 month . Data collect enrollment ( within 30 day device implant ) , routine care follow-up visit 3 month , 6 month , 12 month , 18 month 24 month .</brief_summary>
	<brief_title>A Prospective Clinical Outcomes Registry</brief_title>
	<detailed_description />
	<criteria>1 . Patient sign receive copy Informed Consent form ; 2 . Patient implanted St. Jude Medical Neuromodulation system , include battery and/or SCS lead ; 3 . Patient 18 year age old . 4 . Patient currently participate another clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>SCS</keyword>
	<keyword>St. Jude Medical</keyword>
	<keyword>Neuromodulation</keyword>
</DOC>